Complement C5a inhibition: a new form of COVID-19 treatment for mechanically ventilated patients?

Authors	Andre C Kalil, Michael Proschan
Journal	The Lancet. Respiratory medicine (Lancet Respir Med) Vol. 10 Issue 12 Pg. 1103-1104 (12 2022) ISSN: 2213-2619 [Electronic] England
PMID	36108660 (Publication Type: Journal Article, Comment)
Chemical References	Complement C5a
Topics	Humans Complement C5a (antagonists & inhibitors) COVID-19 (therapy) COVID-19 Drug Treatment Respiration, Artificial (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!